129 related articles for article (PubMed ID: 10557056)
1. Detection of MUM1/IRF4-IgH fusion in multiple myeloma.
Yoshida S; Nakazawa N; Iida S; Hayami Y; Sato S; Wakita A; Shimizu S; Taniwaki M; Ueda R
Leukemia; 1999 Nov; 13(11):1812-6. PubMed ID: 10557056
[TBL] [Abstract][Full Text] [Related]
2. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies.
Tsuboi K; Iida S; Inagaki H; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Kikuchi M; Komatsu H; Banno S; Wakita A; Nakamura S; Eimoto T; Ueda R
Leukemia; 2000 Mar; 14(3):449-56. PubMed ID: 10720141
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma.
Iida S; Rao PH; Butler M; Corradini P; Boccadoro M; Klein B; Chaganti RS; Dalla-Favera R
Nat Genet; 1997 Oct; 17(2):226-30. PubMed ID: 9326949
[TBL] [Abstract][Full Text] [Related]
4. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization.
Finelli P; Fabris S; Zagano S; Baldini L; Intini D; Nobili L; Lombardi L; Maiolo AT; Neri A
Blood; 1999 Jul; 94(2):724-32. PubMed ID: 10397739
[TBL] [Abstract][Full Text] [Related]
5. Double-hit myeloma with IGH/MYC and IGH/CCND1 translocations.
Ji M; Jang S; Lee JH; Seo EJ
Ann Hematol; 2013 Aug; 92(8):1129-31. PubMed ID: 23307601
[No Abstract] [Full Text] [Related]
6. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription-polymerase chain reaction analysis of IGH-MMSET fusion transcripts.
Malgeri U; Baldini L; Perfetti V; Fabris S; Vignarelli MC; Colombo G; Lotti V; Compasso S; Bogni S; Lombardi L; Maiolo AT; Neri A
Cancer Res; 2000 Aug; 60(15):4058-61. PubMed ID: 10945609
[TBL] [Abstract][Full Text] [Related]
7. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
[TBL] [Abstract][Full Text] [Related]
8. Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma.
Martin LD; Harizanova J; Righolt CH; Zhu G; Mai S; Belch AR; Pilarski LM
Genes Chromosomes Cancer; 2013 Jun; 52(6):523-37. PubMed ID: 23460268
[TBL] [Abstract][Full Text] [Related]
9. Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations.
Hanamura I; Iida S; Akano Y; Hayami Y; Kato M; Miura K; Harada S; Banno S; Wakita A; Kiyoi H; Naoe T; Shimizu S; Sonta SI; Nitta M; Taniwaki M; Ueda R
Jpn J Cancer Res; 2001 Jun; 92(6):638-44. PubMed ID: 11429052
[TBL] [Abstract][Full Text] [Related]
10. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Nakazawa N; Taniwaki M; Yawata Y; Ueki A
Int J Oncol; 1999 Dec; 15(6):1205-12. PubMed ID: 10568829
[TBL] [Abstract][Full Text] [Related]
11. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.
Chesi M; Nardini E; Lim RS; Smith KD; Kuehl WM; Bergsagel PL
Blood; 1998 Nov; 92(9):3025-34. PubMed ID: 9787135
[TBL] [Abstract][Full Text] [Related]
12. Interphase detection of immunoglobulin heavy chain gene translocations with specific oncogene loci in 173 patients with B-cell lymphoma.
Tamura A; Miura I; Iida S; Yokota S; Horiike S; Nishida K; Fujii H; Nakamura S; Seto M; Ueda R; Taniwaki M
Cancer Genet Cytogenet; 2001 Aug; 129(1):1-9. PubMed ID: 11520558
[TBL] [Abstract][Full Text] [Related]
13. Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia.
Miura K; Iida S; Hanamura I; Kato M; Banno S; Ishida T; Kusumoto S; Takeuchi G; Miwa H; Nitta M; Inagaki H; Eimoto T; Nomura K; Taniwaki M; Ueda R
Cancer Sci; 2003 Apr; 94(4):350-4. PubMed ID: 12824903
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.
Shaughnessy J; Gabrea A; Qi Y; Brents L; Zhan F; Tian E; Sawyer J; Barlogie B; Bergsagel PL; Kuehl M
Blood; 2001 Jul; 98(1):217-23. PubMed ID: 11418483
[TBL] [Abstract][Full Text] [Related]
15. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas.
Feldman AL; Law M; Remstein ED; Macon WR; Erickson LA; Grogg KL; Kurtin PJ; Dogan A
Leukemia; 2009 Mar; 23(3):574-80. PubMed ID: 18987657
[TBL] [Abstract][Full Text] [Related]
16. Interphase detection of t(4;14)(p16.3;q32.3) by in situ hybridization and FGFR3 overexpression in plasma cell malignancies.
Nakazawa N; Nishida K; Tamura A; Kobayashi M; Iwai T; Horiike S; Nishigaki H; Otsuki T; Tomiyama Y; Fujii H; Kashima K; Taniwaki M
Cancer Genet Cytogenet; 2000 Mar; 117(2):89-96. PubMed ID: 10704676
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel IGH-MMSET fusion transcript in a human myeloma cell line with the t(4;14)(p16.3;q32) chromosomal translocation.
Intini D; Fabris S; Storlazzi T; Otsuki T; Ciceri G; Verdelli D; Lombardi L; Rocchi M; Neri A
Br J Haematol; 2004 Aug; 126(3):437-9. PubMed ID: 15257719
[No Abstract] [Full Text] [Related]
19. Interphase detection of BCL6/IgH fusion gene in non-Hodgkin lymphoma by fluorescence in situ hybridization.
Ueda Y; Nishida K; Miki T; Horiike S; Kaneko H; Yokota S; Misawa S; Abe T; Kashima K; Taniwaki M
Cancer Genet Cytogenet; 1997 Dec; 99(2):102-7. PubMed ID: 9398863
[TBL] [Abstract][Full Text] [Related]
20. MYC amplification on double minute chromosomes in plasma cell leukemia with double IGH/CCND1 fusion genes.
Yamamoto K; Yakushijin K; Ito M; Goto H; Higashime A; Kajimoto K; Hayashi Y; Matsuoka H; Minami H
Cancer Genet; 2020 Apr; 242():35-40. PubMed ID: 32035866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
